The FDA has proposed changing the classification of marijuana from a Schedule I to a Schedule III drug. What impacts could this regulatory status change have on public health and drug regulation around the U.S.? Let's listen in.
Join Cameron English, Dr. Chuck Dinerstein and Dr. Barbara Billauer as they examine marijuana's evolving legal status on Episode 63 of the Science Dispatch podcast:
“The Controlled Substances Act (CSA) places all substances that were in some manner regulated under existing federal law into one of five schedules. This placement is based on the substance’s medical use, potential for abuse, and safety or dependence liability.” The FDA has proposed changing the classification of marijuana from a Schedule I to a Schedule III drug. Let’s break down its thinking.
Listen to the Science Dispatch on iTunes Spotify, Stitcher and Google Podcasts. Or add the RSS feed to your favorite podcast app. Join our Dispatch newsletter to get these stories and more delivered to your inbox.
